152 related articles for article (PubMed ID: 21741447)
1. Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.
Viikki M; Huuhka K; Leinonen E; Illi A; Setälä-Soikkeli E; Huuhka M; Mononen N; Lehtimäki T; Kampman O
Neurosci Lett; 2011 Aug; 501(1):20-4. PubMed ID: 21741447
[TBL] [Abstract][Full Text] [Related]
2. Female sexual dysfunction in patients with major depressive disorder (MDD) treated with selective serotonin reuptake inhibitor (SSRI) and its association with serotonin 2A-1438 G/A single nucleotide polymorphisms.
Masiran R; Sidi H; Mohamed Z; Mohd Nazree NE; Nik Jaafar NR; Midin M; Das S; Mohamed Saini S
J Sex Med; 2014 Apr; 11(4):1047-1055. PubMed ID: 24533444
[TBL] [Abstract][Full Text] [Related]
3. HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.
Kishi T; Yoshimura R; Kitajima T; Okochi T; Okumura T; Tsunoka T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Nakamura J; Ozaki N; Iwata N
Neuromolecular Med; 2010 Sep; 12(3):237-42. PubMed ID: 19937159
[TBL] [Abstract][Full Text] [Related]
4. 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
Illi A; Setälä-Soikkeli E; Viikki M; Poutanen O; Huhtala H; Mononen N; Lehtimäki T; Leinonen E; Kampman O
Neuroreport; 2009 Aug; 20(12):1125-8. PubMed ID: 19590397
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic receptor gene polymorphism and response to selective serotonin reuptake inhibitors in ethnic Malay patients with first episode of major depressive disorder.
Badamasi IM; Lye MS; Ibrahim N; Abdul Razaq NA; Ling KH; Stanslas J
Pharmacogenomics J; 2021 Aug; 21(4):498-509. PubMed ID: 33731884
[TBL] [Abstract][Full Text] [Related]
6. P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.
Viikki M; Kampman O; Anttila S; Illi A; Setälä-Soikkeli E; Huuhka M; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2011 Apr; 493(3):127-30. PubMed ID: 21335057
[TBL] [Abstract][Full Text] [Related]
7. Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis.
Lin JY; Jiang MY; Kan ZM; Chu Y
J Affect Disord; 2014 Oct; 168():430-8. PubMed ID: 25108775
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression.
Viikki M; Anttila S; Kampman O; Illi A; Huuhka M; Setälä-Soikkeli E; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2010 Jun; 477(3):105-8. PubMed ID: 20417690
[TBL] [Abstract][Full Text] [Related]
9. Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
Perlis RH; Fijal B; Adams DH; Sutton VK; Trivedi MH; Houston JP
Biol Psychiatry; 2009 May; 65(9):785-91. PubMed ID: 19095219
[TBL] [Abstract][Full Text] [Related]
10. A preliminary association study between serotonin transporter (5-HTTLPR), receptor polymorphisms (5-HTR1A, 5-HTR2A) and depression symptom-clusters in a north Indian population suffering from Major Depressive Disorder (MDD).
Basu A; Chadda RK; Sood M; Kaur H; Kukreti R
Asian J Psychiatr; 2019 Jun; 43():184-188. PubMed ID: 31228794
[TBL] [Abstract][Full Text] [Related]
11. Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women.
Masiran R; Sidi H; Mohamed Z; Mohamed Saini S; Nik Jaafar NR
Asia Pac Psychiatry; 2013 Apr; 5 Suppl 1():41-9. PubMed ID: 23857836
[TBL] [Abstract][Full Text] [Related]
12. TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response.
Viikki M; Kampman O; Illi A; Setälä-Soikkeli E; Anttila S; Huuhka M; Nuolivirta T; Poutanen O; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2010 Jan; 468(1):80-4. PubMed ID: 19874868
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 2A receptor gene (HTR2A) regulatory variants: possible association with severity of depression symptoms in children with autism spectrum disorder.
Gadow KD; Smith RM; Pinsonneault JK
Cogn Behav Neurol; 2014 Jun; 27(2):107-16. PubMed ID: 24968012
[TBL] [Abstract][Full Text] [Related]
14. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
[TBL] [Abstract][Full Text] [Related]
15. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of association between the -1438A/G (rs6311) polymorphism of the serotonin 2A receptor gene and major depressive disorder.
Jin C; Xu W; Yuan J; Wang G; Cheng Z
Neurol Res; 2013 Jan; 35(1):7-14. PubMed ID: 23317793
[TBL] [Abstract][Full Text] [Related]
17. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
18. Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Tsunoka T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
Neurosci Res; 2009 Jun; 64(2):231-4. PubMed ID: 19428704
[TBL] [Abstract][Full Text] [Related]
19. Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.
Basu A; Chadda RK; Sood M; Kaur H; Kukreti R
Indian J Med Res; 2015 Jul; 142(1):40-5. PubMed ID: 26261165
[TBL] [Abstract][Full Text] [Related]
20. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
